Literature DB >> 687501

Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.

M Frisk-Holmberg, P O Edlund, L Paalzow.   

Abstract

1 The kinetics of clonidine and its relation to the blood pressure response after single intravenous doses of 75 micrograms--275 micrograms in hypertensive patients were determined. 2 Clonidine disposition could be described by a two compartment open model and pharmacokinetic parameters show a rapid distribution phase of 20--30 min and a mean plasma clearance of 4.6 ml min-1 kg-1 (75--200 microgram). The half-life of the beta-phase was found to be in the range of 7.4--11.4 h. Indications of dose dependent kinetics were obtained. 3 A dose-dependent decrease in blood pressure was obtained. 4 The maximal reduction in MAP (mean arterial blood pressure) was significantly (P less than 0.01) related to plasma concentrations of clonidine. 5 The reduction in MAP was always related to plasma concentrations of clonidine (r = 0.88, P less than 0.01) when pseudoequilibrium of distribution of the drug was achieved.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687501      PMCID: PMC1429456          DOI: 10.1111/j.1365-2125.1978.tb04589.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.

Authors:  D S Davies; A M Wing; J L Reid; D M Neill; P Tippett; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1977-05       Impact factor: 6.875

2.  Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity.

Authors:  J Brod; L Horbach; H Just; J Rosenthal; R Nicolescu
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

3.  Prolonged treatment with clonidine: comparative antihypertensive effects alone and with a diuretic agent.

Authors:  W J Mroczek; M Davidov; F A Finnerty
Journal:  Am J Cardiol       Date:  1972-10       Impact factor: 2.778

4.  Clonidine hydrochloride in the treatment of hypertension.

Authors:  S W Hoobler; E Sagastume
Journal:  Am J Cardiol       Date:  1971-07       Impact factor: 2.778

5.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M L Orme; M D Rawlins; J Ostman
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

6.  Apparent resistance to hypotensive effect of clonidine.

Authors:  L M Wing; J L Reid; D S Davies; H J Dargie; C T Dollery
Journal:  Br Med J       Date:  1977-01-15

7.  Quantitative gas-liquid chromatographic determination of clonidine in plasma.

Authors:  P O Edlumd; L K Paalzow
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-01

8.  Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.

Authors:  G Leonetti; G Mayer; A Morganti; L Terzoli; A Zanchetti; G Bianchetti; E Di Salle; P L Morselli; C A Chidsey
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06
  8 in total
  14 in total

Review 1.  Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.

Authors:  R W Piepho; K J Fendler
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 2.  Is clonidine an effective smoking cessation therapy?

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

3.  New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man.

Authors:  D Arndts; J Doevendans; R Kirsten; B Heintz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  The factors influencing the time course of drug action at alpha-adrenoceptors: an investigation of the effects of clonidine in the pithed rat.

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1980-02       Impact factor: 8.739

5.  The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents.

Authors:  J L Reid
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

6.  Tissue pharmacokinetics of clonidine in rats.

Authors:  E L Conway; B Jarrott
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

7.  Antihypertensive effects of lofexidine in patients with essential hypertension.

Authors:  T C Fagan; S S Bloomfield; T D Cowart; R H Corns-Hurwitz; R J Lipicky; E C Conradi; C Y Hsu; W J Grossman; G E Harmon; W J Degenhart; A W Sinkfield; T E Gaffney
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

8.  Clonidine kinetics in man--evidence for dose dependency and changed pharmacokinetics during chronic therapy.

Authors:  M Frisk-Holmberg; L Paalzow; P O Edlund
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

9.  Relationship between the cardiovascular effects and steady-state kinetics of clonidine in hypertension. Demonstration of a therapeutic window in man.

Authors:  M Frisk-Holmberg; L Paalzow; L Wibell
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of clonidine.

Authors:  D T Lowenthal; K M Matzek; T R MacGregor
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.